4//SEC Filing
David Glenn 4
Accession 0001104659-24-013213
CIK 0001069899other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:00 PM ET
Size
6.9 KB
Accession
0001104659-24-013213
Insider Transaction Report
Form 4
David Glenn
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2024-02-09+300,000→ 300,000 total→ Class A Common Stock (300,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock.
- [F2]On February 9, 2024 (the "Grant Date"), the reporting person was granted 300,000 RSUs pursuant to the Issuer's 2008 Incentive Plan and an RSU award agreement (the "Award Agreement").
- [F3]Pursuant to the Award Agreement, (i) 150,000 RSUs will be subject to time vesting (collectively, the "Time Vesting RSUs") and will vest in equal installments on each of the first five anniversaries of the Grant Date, subject to continued service through each such vesting date, and (ii) 150,000 RSUs will be subject to performance vesting (collectively, the "Performance Vesting RSUs") and will vest (with linear interpolation to apply for achievement between increments) based upon achievement of the arithmetic average of Phibro Animal Health Corporation's closing stock price per share for each trading day in the 90-calendar day period ending five years from the Grant Date, from $20 to $60 and above, subject to Mr. David's continued employment on such date. Time Vesting RSUs and Performance Vesting RSUs, in each case, are subject to earlier vesting upon certain qualifying termination events.
Documents
Issuer
PHIBRO ANIMAL HEALTH CORP
CIK 0001069899
Entity typeother
Related Parties
1- filerCIK 0001606256
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 5:00 PM ET
- Size
- 6.9 KB